China Universal Asset Management Co., Ltd. I Mab Transaction History

China Universal Asset Management Co., Ltd.

$773 Million
Q1 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$1.18 - $3.06 $1,045 - $2,711	886 Added 98.12%	1,789 $2,000
Q3 2023 Oct 30, 2023	BUY	$1.18 - $3.06 $1,045 - $2,711	886 Added 98.12%	1,789 $2,000
Q2 2023 May 21, 2024	SELL	$2.95 - $3.85 $64 - $84	-22 Reduced 2.38%	903 $2,000
Q2 2023 Jul 27, 2023	SELL	$2.95 - $3.85 $64 - $84	-22 Reduced 2.38%	903 $3,000
Q1 2023 May 21, 2024	BUY	$3.08 - $7.39 $1,145 - $2,749	372 Added 67.27%	925 $3,000

Q1 2023 Apr 27, 2023	BUY	$3.08 - $7.39 $1,145 - $2,749	372 Added 67.27%	925 $3,000
Q4 2022 May 21, 2024	BUY	$3.22 - $4.86 $1,780 - $2,687	553 New	553 $2,000
Q4 2022 Jan 31, 2023	BUY	$3.22 - $4.86 $180 - $272	56 Added 11.27%	553 $2,000
Q3 2022 Oct 21, 2022	BUY	$4.01 - $12.34 $1,992 - $6,132	497 New	497 $2,000

Others Institutions Holding IMAB

# of Institutions

Shares Held

16M

Call Options Held

11.9K

Put Options Held

3.5K

Hhlr Advisors, Ltd. Grand Cayman, E9

6.91M
Shares

$10.9 Million
0.29% of portfolio
Decheng Capital Management Iii (Cayman), LLC

4.17M
Shares

$6.58 Million
3.04% of portfolio
David A. Siegel Two Sigma Advisers, LP | New York, Ny

617K
Shares

$975,018
0.0% of portfolio
Two Sigma Investments, LP New York, NY

576K
Shares

$909,416
0.0% of portfolio
Temasek Holdings (Private) LTD Singapore, U0

567K
Shares

$895,307
0.01% of portfolio

View Full List

About I-Mab

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $131M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

More about IMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account